Crude Oil Futures Maintain Positive Bias as Rally Potential Emerges Chinas Seven Titans Tech Stocks Decline as Deflation Concerns Eclipse AI Optimism Red Cross Volunteer Ebola Deaths in DR Congo Highlight Public Health and Economic Risks Pokmon Card Market Surges as Nostalgia Speculation and Celebrity Investors Drive MultiMillion Dollar Sales Southwest Airlines CEO No Demand Drop Despite Higher Fares Cautiously Optimistic on Indian Markets as Earnings Revival Takes Center Stage Arvind Sanger EOG Q1 2026 Earnings Strong EPS Beat Drives Upbeat Investor Sentiment ALDX Q1 2026 Earnings Narrower Loss Beats Estimates Pipeline Progress Highlights TRTX Q1 2026 Earnings EPS Slightly Misses Estimates Stock Rises 073 First Financial Bancorp FFBC Q1 2026 Earnings Earnings Beat Expectations as Core Operations Hold Steady PAYO Q1 2026 Earnings EPS Surprises to the Upside Stock Slightly Lower After Report BRC Group Holdings RILYZ Q1 2024 Earnings Bondholder Impact Amid No Revenue Visibility and Negative EPS Avalon Holdings AWX Edges Higher as Stock Tests Key Resistance Zone Palladyne AI PDYN Moves Higher Gains 319 in Latest Session Opendoor Technologies OPEN Holds Near Support as Modest Decline Reflects Cautious Market Sentiment IM Cannabis Corp IMCC Edges Higher Amid Tight Trading Range VAALCO Energy EGY Holds Support Amid Slight Decline Key Levels in Focus EU Parliament Approves Controversial US Tariff Deal Amid Trade Policy Uncertainty UVSP Q1 2026 Earnings EPS Surges 15 Above Estimates on Strong Core Operations SaverOne SVRE Plunges 1266 as Selling Pressure Intensifies Key Support in Focus BRSP Q1 2026 Earnings EPS Misses Estimates Amid Challenging Market Conditions SUNC Q1 2026 Earnings Significant EPS Miss Highlights Operational Headwinds Winmark Q1 2026 Earnings EPS Misses Estimates Stock Shows Modest Gain California BanCorp BCAL Q1 2026 Earnings EPS Beats Estimates by 276 on Steady Operational Execution EQX Q1 2026 Earnings EPS Falls Just Short of Estimates as Gold Production Remains Steady SVRA Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Continues Pipeline Progress BMY Q1 2026 Earnings EPS Beat on Cost Discipline and Operational Execution